Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5229711 | 6231103 | I | 5229711-5 | 20070111 | 20070122 | 20070206 | EXP | JP-ELI_LILLY_AND_COMPANY-JP200701004526 | ELI LILLY AND COMPANY | 65 | YR | M | Y | 47 | KG | 20070205 | MD | JAPAN |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5229711 | 1008117660 | PS | DULOXETINE HYDROCHLORIDE | 2 | 21427 | ||||||
5229711 | 1008117661 | SS | DULOXETINE HYDROCHLORIDE | 2 | 021427 | ||||||
5229711 | 1008117662 | C | HALCION | 1 | ORAL | 0.5 MG, DAILY (1/D) |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5229711 | 1008117660 | MAJOR DEPRESSION |
5229711 | 1008117662 | INSOMNIA |
Outcome of event
Event ID | OUTC COD |
---|---|
5229711 | HO |
Reactions reported
Event ID | PT |
---|---|
5229711 | ALANINE AMINOTRANSFERASE INCREASED |
5229711 | ASPARTATE AMINOTRANSFERASE INCREASED |
5229711 | BLOOD LACTATE DEHYDROGENASE INCREASED |
5229711 | BLOOD TRIGLYCERIDES INCREASED |
5229711 | CONVULSION |
5229711 | DECREASED APPETITE |
5229711 | GAMMA-GLUTAMYLTRANSFERASE INCREASED |
5229711 | HEPATIC FUNCTION ABNORMAL |
5229711 | IRRITABILITY |
5229711 | LIVER DISORDER |
5229711 | NAUSEA |
5229711 | THIRST |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5229711 | 1008117660 | 20061228 | 20070104 | 8 | DAY |
5229711 | 1008117661 | 20070105 | 20070108 | 4 | DAY |
5229711 | 1008117662 | 20061221 |